Browse > Article

Anti-apoptotic Effect of Bojungbangam-tang Ethanol Extract on Cisplatin-Induced Apoptosis in Rat Mesangial Cells  

Kim, Nam-Su (Department of Oriental Regabilitation Medicine, College of Oriental Medicine, Wonkwang University)
Ju, Sung-Min (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Kwon, Young-Dal (Department of Oriental Regabilitation Medicine, College of Oriental Medicine, Wonkwang University)
Shin, Byung-Cheul (Department of Oriental Regabilitation Medicine, College of Oriental Medicine, Wonkwang University)
Ahn, Kyoo-Seok (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University)
Kim, Sung-Hoon (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University)
Song, Yung-Sun (Department of Oriental Regabilitation Medicine, College of Oriental Medicine, Wonkwang University)
Jeon, Byung-Hun (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.20, no.6, 2006 , pp. 1664-1671 More about this Journal
Abstract
Cisplatin is a anti-neoplastic agent which is commonly used for the treatment of solid tumor. Cisplatin activates multiple signal transduction pathways involved in the stress-induced apoptosis in a variety of cell types. Cytotoxicity of cisplatin was detected in rat mesangial cells and the value of $IC_{50}$ is about 20 ${\mu}M$. The treatment of cisplatin to rat mesangial cells showed the apoptotic bodies and DNA fragmentation. The activation of caspase-3, -8, and -9 and proteolytic cleavage of PARP were observed in the rat mesangial cells treated time-dependently with cisplatin. The activation of ERK, p38 and JNK was also observed in the apoptosis induced by cisplatin in rat mesangial cells. The ethanol extract of Bojungbangam-tang (EBJT), a new hergal prescription composed of nine crude drugs, inhibited cisplatin-induced apoptosis in rat mesangial cells. EBJT reduced sub-G1 peak (apoptotic peak) in cisplatin-treated rat mesangial cells. The cisplatin-induced ERK and JNK activation in rat mesangial cells were blocked by EBJT, but EBJT had no effect on p38 activation. Taken together, these results con suggest that EBJT prevents cisplatin-induced apoptotic cell death in rat mesangial cells through inhibition of ERK and JNK activation.
Keywords
Apoptosis; Cisplatin; Rat mesangial Cells; Bojungbangam-tang;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wang, X., Martindale, J.L., Liu, Y. and Holbrook, N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333:291-300, 1998   DOI
2 Sanchez-Perez, I., Murguia, J.R. and Perona, R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16:533-540, 1998   DOI   ScienceOn
3 Mishima, K., Baba, A., Matsuo, M., Itoh, Y. and Oishi, R. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radic. Biol. Med. 40:1564-1577, 2006   DOI   ScienceOn
4 Goldstein, R.S. and Mayor, G.H. Minireview. The nephrotoxicity of cisplatin. Life Sci. 32:685-690, 1983   DOI
5 Ito, Y., Pandey, P., Sporn, M.B., Datta, R., Kharbanda, S. and Kufe, D. The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol. Pharmacol. 59:1094-1099, 2001   DOI
6 DeHaan, R.D., Yazlovitskaya, E.M., Persons, D.L. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother. Pharmacol. 48:383-388, 2001   DOI   ScienceOn
7 Timmer-Bosscha, H., Mulder, N.H. and de Vries, E.G. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br. J. Cancer. 66:227-238, 1992   DOI   ScienceOn
8 Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252, 2000   DOI   ScienceOn
9 Guyton, K,Z,, Liu, Y., Gorospe, M., Xu, Q. and Holbrook, N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:4138-4142, 1996   DOI
10 Zanke, B.W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L.A., Zon, L., Kyriakis, J., Liu, F.F. and Woodgett, J.R. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6:606-613, 1996   DOI   ScienceOn
11 Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995   DOI
12 Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M. and Lord, J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256:34-41, 2000   DOI   ScienceOn
13 Fan, M. and Chambers, T.C. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist. Updat. 4:253-267, 2001   DOI   ScienceOn
14 Persons, D.L., Yazlovitskaya, E.M. and Pelling, J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 275:35778-357785, 2000   DOI   ScienceOn
15 Bulavin, D.V., Higashimoto, Y., Popoff, I.J., Gaarde, W.A., Basrur, V., Potapova, O., Appella, E. and Fornace, A.J. Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411:102-107, 2001   DOI   ScienceOn
16 Nowak, G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J. Biol. Chem. 277:43377-43388, 2002   DOI   ScienceOn
17 Ito, Y., Pandey, P., Place, A., Sporn, M.B., Gribble, G.W., Honda, T., Kharbanda, S. and Kufe D. The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. Cell Growth. Differ. 11:261-267, 2000
18 Hengartner, M.O. The biochemistry of apoptosis. Nature 407:770-776, 2000   DOI   ScienceOn
19 Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K. and Cobb, M.H. Mitogen- activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153-183, 2001   DOI   ScienceOn
20 Brozovic, A., Fritz, G., Christmann, M., Zisowsky, J., Jaehde, U., Osmak, M. and Kaina, B. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int. J. Cancer 112:974-985, 2004   DOI   ScienceOn
21 Sanchez-Perez, I. and Perona, R. Lack of c-Jun activity increases survival to cisplatin. FEBS Lett. 453:151-158   DOI
22 Wang, X., Martindale, J.L. and Holbrook, N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J .Biol. Chem. 275:39435-39443, 2000   DOI   ScienceOn
23 Wright, J.H., Munar, E., Jameson, D.R., Andreassen, P.R., Margolis, R.L., Seger, R. and Krebs, E.G. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA. 96:11335-11340, 1999
24 Eastman, A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34:155-166, 1987   DOI   ScienceOn
25 Kim, Y.K., Kim, H.J., Kwon, C.H., Kim, J.H., Woo, J.S., Jung, J.S. and Kim, J.M. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J. Appl. Toxicol. 25:374-382, 2005   DOI   ScienceOn
26 Wang, X., McGowan, C.H., Zhao, M., He, L., Downey, J.S., Fearns, C., Wang, Y., Huang, S. and Han, J. Involvement of the MKK6-p38gamma cascade in gamma-radiation- induced cell cycle arrest. Mol. Cell Biol. 20:4543-4552, 2000   DOI   ScienceOn
27 Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H. and Mercola, D., Murata, Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 274:31648-31654, 1999   DOI
28 Siddik, Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279, 2003   DOI   ScienceOn
29 Cobb, M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71:479-500, 1999   DOI   ScienceOn
30 Safirstein, R., Winston, J., Goldstein, M., Moel, D., Dikman, S. and Guttenplan, J. Cisplatin nephrotoxicity. Am. J. Kidney Dis. 8:356-367, 1986   DOI
31 Guadagno, T,M, and Ferrell, J.E. Jr. Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts. Science 282:1312-1315, 1998   DOI
32 Lee, S.J., Saiki, I., Hayakawa, Y., Nunome, S., Yamada, H., Kim, S.H. Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangam-tang. Int. Immunopharmacol. 3:147-157, 2000   DOI   ScienceOn